Outcomes Disparities between Black and White Populations in the Surgical Management of Glaucoma

REFERENCES

• Tham Y-C, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology 2014;121:2081–2090.
   Google Scholar
• Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412–1417.
   Google Scholar
• Leske MC, Connell AM, Wu SY, et al. Incidence of open-angle glaucoma: The Barbados Eye Studies: The Barbados Eye Studies Group. Arch Ophthalmol 2001;119:89–95.
   PubMed Web of Science ®Google Scholar
• Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989;96:1363–1368.
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943–1953.
   Google Scholar
• Quigley HA, Tielsch JM, Katz J, Sommer A. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol. 1996;122:355–363.
   PubMed Web of Science ®Google Scholar
• Olateju SO, Ajayi AA. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers. Eye (Lond) 1999;13:758–763.
   PubMed Web of Science ®Google Scholar
• Netland PA, Robertson SM, Sullivan EK, et al. Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension. Adv Ther 2003;20:149–163.
   PubMed Web of Science ®Google Scholar
• Devgan U, Yu F, Kim E, Coleman AL. Surgical undertreatment of glaucoma in black beneficiaries of medicare. Arch Ophthalmol 2000;118:253–256.
   PubMedGoogle Scholar
• Cairns JE. Trabeculectomy: Preliminary report of a new method. Am J Ophthalmol. 1968;66:673–679.
   PubMed Web of Science ®Google Scholar
• Merritt JC. Filtering procedures in American blacks. Ophthalmic Surg 1980;11:91–94.
   PubMedGoogle Scholar
• Miller RD, Barber JC. Trabeculectomy in black patients. Ophthalmic Surg 1981;12:46–50.
   PubMedGoogle Scholar
• The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race: Seven-year results. Ophthalmology 1998;105:1146–1164.
   PubMed Web of Science ®Google Scholar
• The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol 2001;132:311–320.
   PubMed Web of Science ®Google Scholar
• The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 2002;134:481–498.
   PubMed Web of Science ®Google Scholar
• Ederer F, Gaasterland DA, Dally LG, et al. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651–664.
   PubMed Web of Science ®Google Scholar
• Broadway D, Grierson I, Hitchings R. Racial differences in the results of glaucoma filtration surgery: Are racial differences in the conjunctival cell profile important? Br J Ophthalmol. 1994;78:466–475.
   PubMed Web of Science ®Google Scholar
• Stürmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy: Assessment of risk factors for failure. Ophthalmology 1993;100:928–939.
   PubMed Web of Science ®Google Scholar
• McMillan TA, Stewart WC, Hennis HL, et al. Histologic differences in the conjunctiva of black and white glaucoma patients. Ophthalmic Surg 1992;23:762–765.
   PubMedGoogle Scholar
• Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 2001;10:237–249.
   PubMed Web of Science ®Google Scholar
• Egbert PR, Williams AS, Singh K, et al. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol 1993;116:612–616.
   PubMed Web of Science ®Google Scholar
• Mielke C, Dawda VK, Anand N. Intraoperative 5-fluorouracil application during primary trabeculectomy in Nigeria: A comparative study. Eye (Lond) 2003;17:829–834.
   PubMed Web of Science ®Google Scholar
• Mermoud A, Salmon JF, Murray AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol 1993;116:72–78.
   PubMed Web of Science ®Google Scholar
• Mwanza JC, Kabasele PM. Trabeculectomy with and without mitomycin-C in a black African population. Eur J Ophthalmol 2001;11:261–263.
   PubMed Web of Science ®Google Scholar
• Kim HY, Egbert PR, Singh K. Long-term comparison of primary trabeculectomy with 5-fluorouracil versus mitomycin C in West Africa. J Glaucoma 2008;17:578–583.
   PubMed Web of Science ®Google Scholar
• Scott IU, Greenfield DS, Schiffman J, et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol 1998;116:286–291.
   PubMedGoogle Scholar
• Budenz DL, Pyfer M, Singh K, et al. Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. Ophthalmic Surg Lasers 1999;30:367–374.
   PubMedGoogle Scholar
• Morris DA, Peracha MO, Shin DH, et al. Risk factors for early filtration failure requiring suture release after primary glaucoma triple procedure with adjunctive mitomycin. Arch Ophthalmol 1999;117:1149–1154.
   Google Scholar
• Shin DH, Hughes BA, Song MS, et al. Primary glaucoma triple procedure with or without adjunctive mitomycin: Prognostic factors for filtration failure. Ophthalmology 1996;103:1925–1933.
   Google Scholar
• Jampel HD, Solus JF, Tracey PA, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology 2012;119:712–722.
   PubMed Web of Science ®Google Scholar
• Grehn F, Holló; G, Khaw P, Overton B, Wilson R, Vogel R, Smith Z. Factors affecting the outcome of trabeculectomy: An analysis based on combined data from two Phase III studies of an antibody to transforming growth factor β2, CAT-152. Ophthalmology 2007;114:1831–1838.
   Google Scholar
• Dahan E, Carmichael TR. Implantation of a miniature glaucoma device under a scleral flap. J Glaucoma 2005;14:98–102.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang X. Meta-analysis of randomized controlled trials comparing EX-Press implantation with trabeculectomy for open-angle glaucoma. PloS One 2014;9:e100578. doi: 10.1371/journal.pone.0100578.
   Google Scholar
• Wang W, Zhou M, Huang W, Zhang X. Ex-Press implantation versus trabeculectomy in uncontrolled glaucoma: A meta-analysis. PloS One 2013;8:e63591. doi: 10.1371/journal.pone.0063591.
   Google Scholar
• Wagschal LD, Trope GE, Jinapriya D, et al. Prospective randomized study comparing Ex-Press to trabeculectomy: 1-year results. J Glaucoma 2015; 8:624–9.
   Google Scholar
• John AM, Berezina TL, Fechtner RD, Khouri AS. Long term outcomes of Ex-Press glaucoma filtration surgery in African American patients with glaucoma. Invest Ophthalmol Vis Sci 2014;55:3170–3170.
   Google Scholar
• Salim S, Du H, Boonyaleephan S, Wan J. Surgical outcomes of the Ex-Press glaucoma filtration device in African American and white glaucoma patients. Clin Ophthalmol 2012;6:955–962.
   PubMedGoogle Scholar
• Freedman J, Ferri S. Long-term comparison using Ex-Press glaucoma shunt in black and white patients. Can J Ophthalmol 2014;49:200–204.
   PubMed Web of Science ®Google Scholar
• Mariotti C, Dahan E, Nicolai M, et al. Long-term outcomes and risk factors for failure with the EX-Press glaucoma drainage device. Eye (Lond) 2014;28:1–8.
   PubMed Web of Science ®Google Scholar
• Mastropasqua L, Agnifili L, Salvetat ML, et al. In vivo analysis of conjunctiva in canaloplasty for glaucoma. Br J Ophthalmol 2012;96:634–639.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Clinical evaluation of the aqueous outflow system in primary open-angle glaucoma for canaloplasty. Invest Ophthalmol Vis Sci 2010;51:1498–1504.
   Google Scholar
• Grieshaber MC. [Channelography and mechanism of action in canaloplasty]. Ophthalmologe 2015;112:319–324.
   PubMed Web of Science ®Google Scholar
• Ayyala RS, Chaudhry AL, Okogbaa CB, Zurakowski D. Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months’ follow-up. Ophthalmology 2011;118:2427–2433.
   Google Scholar
• Brüggemann A, Despouy JT, Wegent A, Müller M. Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series. J Glaucoma 2013;22:577–583.
   PubMed Web of Science ®Google Scholar
• Matlach J, Dhillon C, Hain J, et al. Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: A prospective randomized clinical trial. Acta Ophthalmol 2015;93:8:753–61. doi: 10.1111/aos.12722.
   PubMed Web of Science ®Google Scholar
• Eldaly MA, Bunce C, Elsheikha OZ, Wormald R. Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database Syst Rev 2014; 2: CD007059. doi: 10.1002/14651858.CD007059.pub2.
   PubMed Web of Science ®Google Scholar
• Dietlein TS, Jacobi PC, Lüke C, Krieglstein GK. Morphological variability of the trabecular meshwork in glaucoma patients: Implications for non-perforating glaucoma surgery. Br J Ophthalmol. 2000;84:1354–1359.
   Google Scholar
• Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999;25:316–322.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Peckar C, Pienaar A, et al. Long-term results of up to 12 years of over 700 cases of viscocanalostomy for open-angle glaucoma. Acta Ophthalmol 2015;93:362–367.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Canaloplasty for primary open-angle glaucoma: Long-term outcome. Br J Ophthalmol 2010;94:1478–1482.
   Google Scholar
• Grieshaber MC, Fraenkl S, Schoetzau A, et al. Circumferential viscocanalostomy and suture canal distension (canaloplasty) for whites with open-angle glaucoma. J Glaucoma 2011;20:298–302.
   PubMed Web of Science ®Google Scholar
• Guedes RAP, Guedes VMP, Chaoubah A. Factors associated with non-penetrating deep sclerectomy failure in controlling intraocular pressure. Acta Ophthalmol 2011;89:58–61.
   PubMed Web of Science ®Google Scholar
• Freedman J, Rubin B. Molteno implants as a treatment for refractory glaucoma in black patients. Arch Ophthalmol 1991;109:1417–1420.
   Google Scholar
• Stewart WC, Connor AB, Pitts RA. Prognostic factors and postoperative course following single-plate Molteno implantation. Doc Ophthalmol 1994;86:409–417.
   PubMed Web of Science ®Google Scholar
• Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol. 2001;85:689–695.
   PubMed Web of Science ®Google Scholar
• Mills RP, Reynolds A, Emond MJ, et al. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology 1996;103:299–305.
   PubMed Web of Science ®Google Scholar
• Woodcock MGL, Richards JC, Murray ADN. The last 11 years of Molteno implantation at the University of Cape Town: Refining our indications and surgical technique. Eye (Lond) 2008;22:18–25.
   PubMed Web of Science ®Google Scholar
• WuDunn D, Phan ADT, Cantor LB, et al. Clinical experience with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 2006;113:766–772.
   PubMed Web of Science ®Google Scholar
• Harbick KH, Sidoti PA, et al. Outcomes of inferonasal Baerveldt glaucoma drainage implant surgery. J Glaucoma 2006;15:7–12.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol 2012;153:789–803.
   PubMed Web of Science ®Google Scholar
• Allan EJ, Khaimi MA, Jones JM, et al. Long-term efficacy of the Baerveldt 250 mm2 compared with the Baerveldt 350 mm2 implant. Ophthalmology 2015;122:486–493.
   PubMed Web of Science ®Google Scholar
• Barton K, Gedde SJ, Budenz DL, et al. Ahmed Baerveldt Comparison Study Group: The Ahmed Baerveldt Comparison Study methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology 2011;118:435–442.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Barton K, Feuer WJ, et al. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 2011;118:443–452.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Barton K, Gedde SJ, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 2015;122:308–316.
   PubMed Web of Science ®Google Scholar
• Christakis PG, Tsai JC, Zurakowski D, et al. The Ahmed versus Baerveldt Study: Design, baseline patient characteristics, and intraoperative complications. Ophthalmology 2011;118:2172–2179.
   Google Scholar
• Christakis PG, Kalenak JW, Zurakowski D, et al. The Ahmed Versus Baerveldt study: One-year treatment outcomes. Ophthalmology 2011;118:2180–2189.
   Google Scholar
• Christakis PG, Tsai JC, Kalenak JW, et al. The Ahmed versus Baerveldt study: Three-year treatment outcomes. Ophthalmology 2013;120:2232–2240.
   Google Scholar
• Budenz DL, Gedde SJ, Brandt JD, et al. Baerveldt glaucoma implant in the management of refractory childhood glaucomas. Ophthalmology 2004;111:2204–2210.
   Google Scholar
• Kiage DO, Gradin D, Gichuhi S, Damji KF. Ahmed glaucoma valve implant: Experience in East Africa. Middle East Afr J Ophthalmol. 2009;16:151–155.
   PubMedGoogle Scholar
• T/Giorgis A. Initial clinical experience of tube-shunt surgery in Ethiopian patients with refractory glaucoma. Ethiop Med J 2012;50:159–165.
   PubMedGoogle Scholar
• Coleman AL, Hill R, Wilson MR, et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol 1995;120:23–31.
   PubMed Web of Science ®Google Scholar
• Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999;128:198–204.
   PubMed Web of Science ®Google Scholar
• Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 1998;105:1968–1976.
   Google Scholar
• Ishida K, Netland PA. Ahmed Glaucoma Valve implantation in African American and white patients. Arch Ophthalmol 2006;124:800–806.
   PubMedGoogle Scholar
• Goulet RJ, Phan ADT, Cantor LB, WuDunn D. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 2008;115:1141–1147.
   Google Scholar
• Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch Ophthalmol 1985;103:1482–1484.
   Google Scholar
• Nagar M, Ogunyomade A, O’Brart DPS, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 2005;89:1413–1417.
   Google Scholar
• Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 2004;111:1853–1859.
   Google Scholar
• Tzimis V, Tze L, Ganesh J, et al. Laser trabeculoplasty: An investigation into factors that might influence outcomes. Can J Ophthalmol 2011;46:305–309.
   PubMed Web of Science ®Google Scholar
• Seck SM, Agboton G, Dieng M, et al. [Selective laser trabeculoplasty (SLT): Our experience in African blacks]. J Fr Ophtalmol 2015;38:238–246.
   PubMed Web of Science ®Google Scholar
• Youn J, Cox TA, Allingham RR, Shields MB. Factors associated with visual acuity loss after noncontact transscleral Nd: YAGcyclophotocoagulation. J Glaucoma 1996;5:390–394.
   PubMed Web of Science ®Google Scholar
• Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol 2001;119:345–350.
   PubMed Web of Science ®Google Scholar
• Chen J, Cohn RA, Lin SC, et al. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol 1997;124:787–796.
   PubMed Web of Science ®Google Scholar
• Threlkeld AB, Johnson MHM. Contact transscleral diode cyclophotocoagulation for refractory glaucoma. J Glaucoma 1999;8:3–7.
   PubMed Web of Science ®Google Scholar
• Dewundara S, Hughes B, Momi R, et al. Predictors of failure with transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Invest Ophthalmol Vis Sci 2013;54:1858–1858.
   Google Scholar
• Preussner PR, Ngounou F, Kouogan G. Controlled cyclophotocoagulation with the 940 nm laser for primary open angle glaucoma in African eyes. Graefes Arch Clin Exp Ophthalmol 2010;248:1473–1479.
   Google Scholar
• Higginbotham EJ. Why did my surgery fail, doc? Arch. Ophthalmol 2006;124:903–904.
   Web of Science ®Google Scholar